HSBC Holdings
OCUL icon

HSBC Holdings’s Ocular Therapeutix OCUL Stock Holding History

HSBC Holdings’s Portfolio OCUL Stock Details OCUL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-19,573
Closed -$141K – 3183
2025
Q1 		$141K Buy
19,573
+1,472
+8% +$11.3K ﹤0.01% 2722
2024
Q4 		$152K Buy
18,101
+5,853
+48% +$57.1K ﹤0.01% 2791
2024
Q3 		$107K Sell
12,248
-260
-2% -$2.14K ﹤0.01% 2785
2024
Q2 		$85.9K Buy
12,508
+127
+1% +$784 ﹤0.01% 2760
2024
Q1 		$113K Buy
+12,381
New +$87.9K ﹤0.01% 2824
2023
Q1 		– Sell
-11,940
Closed -$32.9K – 2937
2022
Q4 		$32.9K Buy
+11,940
New +$39.5K ﹤0.01% 2991

Other funds holding OCUL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
SR
Summer Road West Palm Beach, Florida $142M AUM 43.61% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

HSBC Holdings's OCUL Position: Q2 2025 in Review

HSBC Holdings sold out of Ocular Therapeutix (OCUL) in Q2 2025, closing a stake of 19,573 shares — an estimated $141K sold.

HSBC Holdings first reported a position in OCUL in Q4 2022 and held it in 6 quarters. The position peaked at $152K in Q4 2024. 186 funds tracked by Wall St. Rank hold OCUL as of Q2 2025.

  • HSBC Holdings reported no remaining Ocular Therapeutix position as of Q2 2025 after selling out during the quarter.
  • HSBC Holdings sold 19,573 Ocular Therapeutix shares in Q2 2025, an estimated $141K.
  • HSBC Holdings first reported a position in Ocular Therapeutix in Q4 2022 and held it in 6 quarters.
  • HSBC Holdings's Ocular Therapeutix position peaked at $152K in Q4 2024.
  • 186 funds tracked by Wall St. Rank held Ocular Therapeutix as of Q2 2025.

Based on HSBC Holdings's 13F filing for Q2 2025, filed 13 Aug 2025.